Is parenteral methotrexate worth trying?

被引：15

作者：

Osman, A ^{[1
]}

Mulherin, D ^{[1
]}

机构：

[1] Cannock Chase Hosp, Dept Rheumatol, Cannock WS11 2XY, Staffs, England

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2001年 / 60卷 / 04期

关键词：

D O I：

10.1136/ard.60.4.432

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：432 / 432

页数：1

共 7 条

[1] The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis [J].

Godfrey, C ;

Sweeney, K ;

Miller, K ;

Hamilton, R ;

Kremer, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (04) :369-376

[2]

Hamilton RA, 1997, BRIT J RHEUMATOL, V36, P86

[3]

Lindsay G, 2000, RHEUMATOLOGY S1, V39, P88

[4] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[5] Methotrexate use in rheumatoid arthritis [J].

ODell, JR .

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1997, 23 (04) :779-&

[6]

Rau R, 1997, BRIT J RHEUMATOL, V36, P345

[7] Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate [J].

Strand, V ;

Cohen, S ;

Schiff, M ;

Weaver, A ;

Fleischmann, R ;

Cannon, G ;

Fox, R ;

Moreland, L ;

Olsen, N ;

Furst, D ;

Caldwell, J ;

Kaine, J ;

Sharp, J ;

Hurley, F ;

Loew-Friedrich, I .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) :2542-2550

← 1 →